PhosAgro PAO
LSE:PHOR
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
PhosAgro PAO
Current Assets | 211.5B |
Cash & Short-Term Investments | 78.9B |
Receivables | 69.9B |
Other Current Assets | 62.7B |
Non-Current Assets | 386.4B |
Long-Term Investments | 1.8B |
PP&E | 356.7B |
Intangibles | 2.5B |
Other Non-Current Assets | 25.4B |
Current Liabilities | 234B |
Accounts Payable | 16.7B |
Accrued Liabilities | 10.5B |
Other Current Liabilities | 206.9B |
Non-Current Liabilities | 202.7B |
Long-Term Debt | 187.4B |
Other Non-Current Liabilities | 15.3B |
Balance Sheet
PhosAgro PAO
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
30 687
|
29 347
|
7 261
|
2 691
|
9 320
|
8 236
|
8 460
|
21 710
|
13 356
|
29 163
|
|
Cash |
0
|
29 347
|
0
|
2 691
|
9 320
|
8 236
|
8 460
|
21 710
|
13 356
|
29 163
|
|
Cash Equivalents |
30 687
|
0
|
7 261
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Short-Term Investments |
1 656
|
4 902
|
3 282
|
352
|
313
|
251
|
311
|
216
|
58
|
4 933
|
|
Total Receivables |
17 193
|
21 338
|
25 091
|
28 855
|
30 311
|
26 097
|
22 625
|
49 061
|
75 814
|
69 711
|
|
Accounts Receivables |
6 333
|
10 841
|
12 271
|
14 971
|
19 761
|
14 117
|
10 843
|
32 658
|
61 505
|
50 914
|
|
Other Receivables |
10 860
|
10 497
|
12 820
|
13 884
|
10 550
|
11 980
|
11 782
|
16 403
|
14 309
|
18 797
|
|
Inventory |
12 527
|
17 814
|
19 934
|
25 445
|
31 710
|
29 405
|
30 580
|
41 177
|
39 349
|
48 468
|
|
Other Current Assets |
4 775
|
4 626
|
4 922
|
4 872
|
5 875
|
4 964
|
5 654
|
15 018
|
12 737
|
14 978
|
|
Total Current Assets |
66 838
|
78 027
|
60 490
|
62 215
|
77 529
|
68 953
|
67 630
|
127 182
|
141 314
|
167 253
|
|
PP&E Net |
86 086
|
120 952
|
159 397
|
177 447
|
192 990
|
219 356
|
235 201
|
257 636
|
288 069
|
326 240
|
|
PP&E Gross |
0
|
120 952
|
0
|
177 447
|
192 990
|
219 356
|
0
|
257 636
|
288 069
|
326 240
|
|
Accumulated Depreciation |
0
|
49 830
|
0
|
72 021
|
91 604
|
113 283
|
0
|
146 987
|
165 549
|
189 651
|
|
Intangible Assets |
572
|
566
|
1 165
|
1 773
|
1 786
|
1 567
|
1 621
|
1 756
|
2 099
|
2 773
|
|
Note Receivable |
21
|
13
|
754
|
753
|
795
|
673
|
732
|
677
|
8 496
|
7 217
|
|
Long-Term Investments |
13 629
|
1 487
|
1 549
|
1 724
|
1 258
|
1 121
|
1 148
|
2 359
|
604
|
1 672
|
|
Other Long-Term Assets |
12 509
|
15 457
|
5 849
|
7 718
|
11 865
|
10 951
|
13 686
|
15 837
|
15 031
|
20 486
|
|
Total Assets |
179 655
N/A
|
216 502
+21%
|
229 204
+6%
|
251 630
+10%
|
286 223
+14%
|
302 621
+6%
|
320 018
+6%
|
405 447
+27%
|
455 613
+12%
|
525 641
+15%
|
|
Liabilities | |||||||||||
Accounts Payable |
3 902
|
4 763
|
5 574
|
6 291
|
7 674
|
7 393
|
7 453
|
10 967
|
11 406
|
14 469
|
|
Accrued Liabilities |
4 275
|
4 884
|
5 807
|
4 998
|
5 333
|
5 593
|
4 239
|
5 303
|
6 018
|
8 158
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
30 822
|
28 947
|
14 137
|
45 142
|
21 397
|
38 382
|
57 243
|
14 888
|
81 093
|
86 023
|
|
Other Current Liabilities |
9 102
|
8 044
|
11 659
|
10 559
|
9 092
|
13 044
|
22 852
|
35 217
|
29 062
|
86 126
|
|
Total Current Liabilities |
48 101
|
46 638
|
37 177
|
66 990
|
43 496
|
64 412
|
91 787
|
66 375
|
127 579
|
194 776
|
|
Long-Term Debt |
93 002
|
105 565
|
98 239
|
77 534
|
123 253
|
101 437
|
108 092
|
160 540
|
111 444
|
164 528
|
|
Deferred Income Tax |
2 118
|
3 677
|
4 600
|
7 914
|
9 023
|
10 278
|
11 578
|
12 937
|
17 820
|
13 603
|
|
Minority Interest |
149
|
213
|
137
|
129
|
195
|
170
|
129
|
106
|
158
|
84
|
|
Other Liabilities |
453
|
424
|
767
|
950
|
630
|
857
|
945
|
952
|
1 050
|
1 129
|
|
Total Liabilities |
143 823
N/A
|
156 517
+9%
|
140 920
-10%
|
153 517
+9%
|
176 597
+15%
|
177 154
+0%
|
212 531
+20%
|
240 910
+13%
|
258 051
+7%
|
374 120
+45%
|
|
Equity | |||||||||||
Common Stock |
372
|
372
|
372
|
372
|
372
|
372
|
372
|
372
|
372
|
372
|
|
Retained Earnings |
27 966
|
52 119
|
80 418
|
90 247
|
102 316
|
118 290
|
100 338
|
157 424
|
190 664
|
144 658
|
|
Additional Paid In Capital |
7 494
|
7 494
|
7 494
|
7 494
|
7 494
|
7 494
|
7 494
|
7 494
|
7 494
|
7 494
|
|
Other Equity |
0
|
0
|
0
|
0
|
556
|
689
|
717
|
753
|
968
|
1 003
|
|
Total Equity |
35 832
N/A
|
59 985
+67%
|
88 284
+47%
|
98 113
+11%
|
109 626
+12%
|
125 467
+14%
|
107 487
-14%
|
164 537
+53%
|
197 562
+20%
|
151 521
-23%
|
|
Total Liabilities & Equity |
179 655
N/A
|
216 502
+21%
|
229 204
+6%
|
251 630
+10%
|
286 223
+14%
|
302 621
+6%
|
320 018
+6%
|
405 447
+27%
|
455 613
+12%
|
525 641
+15%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
130
|
130
|
130
|
130
|
130
|
130
|
130
|
130
|
130
|
130
|